Sell-Side M&A Advisory — UNGLIN
The Diagnostic Track Record The Mandate Who It's For FAQ Book Discovery Call →
UNGLIN · Sell-Side M&A Advisory

Business Exit Engineering · ASIA · EU · US

See your business the way a serious buyer will.

Most founders sell their businesses as they are. Every issue uncovered in due diligence becomes a discount at closing. Unglin engineers exits around PE deal logic—removing discount triggers and increasing what buyers are willing to pay.

NDA before we start · Globally

6–25% Premium for
proper advisor*
$1M+ Deal
sizes
59% buyers are
PE firms*
$15K Diagnostic
fixed fee
Advisory Landscape

Where Unglin fits.
Why it matters for your deal.

The advisory market is segmented by deal size and who actually runs your process. One option is structured for the $1M–$50M founder-led exit. Understanding which tells you where to spend 30 minutes.

Swipe to compare all options

Business Broker Investment Bank Generic Boutique UNGLIN
Deal Size Fit
Enterprise Value Sub-$2M$100M+Best above $20M $1M–$50M
Senior Involvement
Who Runs Your Deal Volume agent — 10–20 listings simultaneously Analyst team; partner at pitch and key meetings only Partner wins mandate; associates execute Den on every call, every document, every negotiation. No associates, no handoffs.
Pre-Sale Preparation
Buyer-Side Assessment Informal or none Depends on scope Varies — often limited Structured Exit Readiness Diagnostic required before mandate is agreed
CIM Format
Document Type Listing summary Full institutional, sector-specific Institutional template, execution varies PE underwriting format — built on verified Diagnostic outputs, not projections
Fee Structure
How You Pay 10% success only — no retainer Large upfront retainer + 1–2% success fee Monthly retainer + 3–5% success fee Diagnostic ($15K) → monthly retainer (credited at close) + tiered success fee. No fee if deal does not close.
Buyer Access
Buyer Types Local, regional; limited PE access Global — major PE, strategics, public companies PE and strategic, relationship-dependent PE, family offices, strategic acquirers — Asia, Europe, US

Den is not the right advisor for every business. Below $500K EBITDA, a local broker is the right instrument. Above $50M, an institutional mid-market firm with a full analyst team will serve you better. Den will tell you which applies on the discovery call.

Why Founders Leave Value on the Table

Four failure patterns.
One outcome.

Every founder who underperforms at exit shows at least one of these. Most show three. The Diagnostic finds which ones apply before a buyer does.

⚖️

The advisory gap between broker and investment bank is exactly your deal size

Business brokers handle volume at sub-$2M. Investment banks work above $100M. The $1M–$50M founder-led exit sits in a gap where most advisors are either under-resourced for the complexity or uninterested in the economics. The institutional-grade process your deal deserves is not expensive. It is simply rare.

🔑

Key-man risk — buyers price it in before the first meeting

When your revenue depends on your personal relationships, buyers build that risk into the deal structure before you know they've quantified it. They call it key-man risk. They structure it as an earn-out. The result: you stay on for two years post-close working for contingent money, instead of cashing out clean.

📋

Going to market with the business exactly as it is

The business you take to market on day one is the business that gets valued. Every undocumented process, every customer concentration, every founder dependency — buyers find all of it in due diligence. By then, each finding is negotiating leverage used against you, not information you can act on.

📊

Your CIM is not written for who your buyers actually are

59% of buyers in the $5M–$50M enterprise value range are PE firms. They evaluate businesses against their underwriting criteria and hold-period return requirements — not against what a competitor would pay. A CIM written for the wrong buyer produces the wrong buyers, a longer process, and a weaker final number.

Book a 30-Min Discovery Call → Response within one business day
Two Stages. One Outcome.

Most sellers go to market
having never seen their business
the way a buyer sees it.

The Diagnostic answers that question before a single buyer signs an NDA. The Mandate closes the deal built on that foundation. One advisor. Maximum four mandates per year.

1 Start Here
Exit Readiness
Diagnostic

A paid, fixed-scope engagement producing four written deliverables before any mandate is signed: a quality of earnings pre-assessment, a management independence assessment, a documentation gap report, and an indicative valuation range. All deliverables are yours regardless of whether a mandate follows.

You see your business the way a buyer sees it — before they arrive. Every problem the Diagnostic surfaces is a discount you remove before it's applied.
Three Weeks Fixed Fee In-Person Available
2 Then close the deal
Sell-Side
Mandate

Full sell-side transaction advisory built on the Diagnostic outputs. Institutional-grade CIM targeted to the buyer categories most likely to pay the highest multiple for your specific business. Competitive process. LOI to close. Not a listing. A mandate.

You close with the right buyer, at the right price, on the right terms — because the preparation has already done the work most sellers discover they need after the first LOI falls apart.
4–9 Months Typical Institutional CIM Retainer + Success Fee

Mandate scope and fee are agreed after the Diagnostic — when the buyer pool is identified and the deal narrative is verified. Not before you know what the business looks like to a buyer.

Stage 1 — Exit Readiness Diagnostic

See your business the way
a buyer sees it.

Most sellers discover problems when a buyer's due diligence team surfaces them — at which point those problems become negotiating leverage against the seller, not information the seller can act on. The Exit Readiness Diagnostic inverts that dynamic.

Den examines your business through the lens of a PE buyer's underwriting criteria and produces four written deliverables that tell you exactly what you're working with before any buyer signs an NDA. The deliverables are yours. If you proceed to a mandate, they become the foundation of the CIM. If you choose to wait and fix what the Diagnostic surfaces first, the documents retain commercial value as a preparation roadmap.

Diagnostic Fixed Fee
USD15,000
Fixed · No hourly billing · No upsells · Scoped on discovery call

Exact fee confirmed on the 30-minute discovery call after Den understands your business complexity, geography, and deal timeline. Fixed amount before Day 1 — no scope creep, no surprises.

For reference: a buyer's financial due diligence firm charges $15,000–$40,000 for a QoE review — conducted after they have pricing leverage over you. The Diagnostic produces the same analysis before any buyer is involved. All deliverables are yours regardless.
Book Your Discovery Call →

What You Receive

Four written documents delivered in person or via encrypted transfer at the end of Week Three. Yours permanently — not contingent on mandate engagement.

The Four Deliverables

  • Quality of Earnings Pre-Assessment. The add-backs, normalisation adjustments, and EBITDA recasts a buyer's accountant will apply — identified and documented before they find them. Removes the most common source of post-LOI price reductions.
  • Management Independence Assessment. A documented analysis of what happens to revenue, margin, and operations if you step back — in writing, with evidence, in the format a PE buyer's IC memo requires.
  • Documentation Gap Report. The list of items a buyer's due diligence team will request that you currently do not have. Prioritised by deal impact. Gives you 90–180 days to close the gaps before a buyer's clock starts running.
  • Indicative Valuation Range. A documented range with the specific assumptions driving each end — not a headline number, but the model behind it. The first honest answer to what your business is actually worth to a buyer right now.

How the Three Weeks Run

  • Week 1: In-person or video deep-dive. One full day. NDA signed before we start. Financial review, operational walkthrough, customer and staff dependency mapping.
  • Week 2: Den builds the four documents. One clarification call if needed. No continuous input required from you.
  • Week 3: In-person debrief or encrypted document transfer. Full written deliverables plus Den's recommendation on mandate timing and preparation priorities.
Track Record — Completed Mandate
What structured pre-sale preparation delivers

Two failed attempts. One structured preparation. A 4.2x exit multiple on the third.

The situation: A professional services founder operating across Southeast Asia. Recurring revenue, profitable, but no documented delivery methodology. Two prior sale attempts — both buyers walked away at due diligence citing the same issue: the business could not operate without the founder.

The Diagnostic finding: The founder's client relationships, methodology, and quality oversight were entirely undocumented. There was no operational system a buyer could acquire independently of the founder. The business was unsaleable in its current form — not because buyers didn't want it, but because there was nothing transferable to price.

The preparation: Over two quarters, the founder's methodology was extracted and systematised into documented delivery frameworks. An operations manager was developed into a role with independent client management authority. A reporting structure was established that functioned without the founder's daily input.

The mandate: Three targeted acquirers. Competitive process. The CIM arrived with documented management independence, two quarters of operational history, and a post-acquisition transition roadmap. Buyers had evidence, not assertion. That difference closes deals at a higher multiple and without earn-outs.

Transaction details are confidential. Metrics verified from the completed engagement. Outcomes vary by business type, preparation quality, and market conditions. No outcome can be guaranteed.
4.2x Exit multiple achieved — vs 1.5x on both prior failed attempts
60h → 4h Weekly founder involvement post-documentation — key-man risk removed from the deal narrative
Full cash No earn-out, no contingent payments — because management independence was documented, not asserted
14 months From first Diagnostic session to completed transaction, preparation time included
Stage 2 — Sell-Side Mandate

One mandate.
One maximum price.

The Mandate runs the full sell-side process, built on the Diagnostic outputs. Buyer pool identified. Deal narrative verified. What follows is execution.

The complete sell-side process. Nothing outsourced. Nothing delegated.

CIM preparation and institutional positioning targeted to the buyer categories most likely to pay the highest multiple for your specific business. NDA management, buyer qualification, LOI negotiation, due diligence support, and close. The CIM is an underwriting document — written to answer the questions a PE buyer's investment committee will ask, in the order they ask them, with the evidence they require to approve a deal.

Den leads every stage personally. No associates. No handoffs. Typically 4–9 months from mandate signing to close. Scope and fee are agreed after the Diagnostic, when the buyer pool is identified.

No success fee is charged if the deal does not close. Den will decline a mandate he does not believe will close at a price that justifies the engagement for both sides.

Monthly retainer + tiered success fee. The market standard — for good reason.

81% of mid-market M&A advisors charge a monthly retainer in addition to a success fee (Axial/Divestopedia Fee Guide). The retainer aligns incentives: Den is economically committed to managing your process at the pace your deal requires, not the pace that closes his most active mandate first. The retainer is credited against the success fee at close.

Full fee structure — retainer amount, success fee tiers, and minimum floor — disclosed on the discovery call. An advisor working on success-fee only has five mandates running simultaneously and is commercially incentivised to close whichever deal is nearest, not to maximise value on yours. That signal costs sellers months and price.

Den accepts a maximum of four sell-side mandates per year. That constraint is not positioning language — it is the reason the process delivers outcomes a volume brokerage cannot. Every engagement receives his personal attention from the first Diagnostic session to the final wire transfer. If you are the fifth business in a given year, he will tell you that on the discovery call.

2026 Market Conditions

Buyers are active. Capital is deployed.
The premium goes to prepared sellers.

IBBA & M&A Source Market Pulse Q4 2025
72%

72% of M&A intermediaries expect 2026 deal conditions to match or exceed the 2021 peak. Buyers sidelined in 2023–2024 are returning with active mandates and defined acquisition criteria. Prepared sellers entering this window receive competitive processes. Source: IBBA & M&A Source Market Pulse Q4 2025

Firmex / Divestopedia M&A Fee Guide 2024–25
6–25%

Private sellers receive 6–25% higher acquisition premiums when represented by full-service advisors versus unrepresented sellers. On a $5M deal that differential is $300,000–$1,250,000. The advisory fee is a fraction of that in every scenario. Source: Firmex/Divestopedia, mid-market data

Preqin Global Private Equity Report 2025
$3.9T

$3.9 trillion in PE dry powder at record levels — including significant APAC and European allocation. Capital is not the constraint. IBBA Q2 2025 confirms buyers are frustrated with a low level of listed sellers. Prepared sellers with institutional-grade documentation receive competitive offers. Source: Preqin Global PE Report 2025

The pattern is consistent: buyers have capital and are actively seeking quality assets. The ceiling is not buyer appetite — it is seller preparation. Founders who go to market with documented management independence, clean quality of earnings, and a PE-readable CIM close with competitive tension, full cash, and no earn-out. Founders who go without face price reductions applied after months of process.

Who This Is For

The founder this engagement
is built for.

Right fit — book the discovery call
$500K+ annual EBITDA or $2M+ annual revenue. The process economics require real P&L data that supports a transaction producing meaningful economics for both sides.
You make the decision. Owner, founder, or principal level. The engagement does not work through committee processes or with minority partners whose approval you cannot obtain.
Exit horizon 12 months to 5 years. The Diagnostic is most valuable when there is time to act on what it surfaces. A 12-month window is enough for the preparation that eliminates earn-outs.
You want one senior advisor accountable to the outcome. Not a firm. Not a team. One person whose name is on the engagement letter, the CIM, and the phone when the buyer calls.
You understand that preparation is a commercial decision. Sellers who treat the Diagnostic fee as a cost avoid the $300K–$1.25M differential documented above. Sellers who treat it as an investment close clean.
Your business operates in SE Asia, the UK, cross-border, or globally. Den's deal network spans PE, family offices, and strategics across APAC, Europe, the Middle East, and the Americas.
Not the right fit — Den will say so on the call
Under $500K in annual EBITDA. The advisory process does not produce a return that justifies the engagement fee at this stage. A local broker is the right instrument.
Requires Big 4 audit certification or regulated investment banking. Certain procurement processes require certifications Den does not hold. He will refer you to a firm that meets those requirements.
Wants a valuation promise before the Diagnostic. No honest advisor can tell you what your business is worth before examining it. Anyone who does is telling you what you want to hear.
Looking for a passive listing agent. This is an active sell-side process. It requires the seller to be available, engaged, and willing to act on Diagnostic findings.
Business needs a full operational turnaround first. The engagement improves businesses before sale. It does not rescue businesses with structural revenue decline or negative EBITDA. Fix the business, then return.
Transaction above $30M enterprise value. An institutional mid-market firm with a full analyst team will serve you better at this level. Den refers these directly on the discovery call.
Not Ready to Call Yet?

Download the Exit Readiness
Self-Assessment.

Eight questions that map your business against the four most common deal-killers PE buyers apply in due diligence. The same diagnostic framework Den uses before an engagement. Free. Yours to keep. Message Den on WhatsApp with the word "Checklist" — he will send it within one business day.

Get the Checklist →

No call required. No follow-up pressure. Den sends the checklist directly.

Who Does the Work
Den Unglin — Managing Director, UNGLIN
Den Unglin Managing Director

Every mandate.
Led by Den.

Den spent 18 years building and exiting businesses across 12 markets — not at a bank, not at a consulting firm, but inside the operations. He has been the founder whose business depended on a single key person, the CEO who could not step away, and the seller who went to market without knowing what a PE buyer's investment committee actually evaluates. He knows each of those failure modes from the inside.

He moved into sell-side advisory because he had sat on both sides of enough due diligence processes to understand a specific gap in the $1M–$50M market: the sellers who need institutional-quality process cannot access it, and the advisors who offer it are either too large, too expensive, or uninterested in deals below their fee threshold.

He takes a maximum of four sell-side mandates per year. Every engagement begins with a direct conversation with Den — not a qualifying call with a sales team. NDA signed before any work begins.

Den is currently advising on active sell-side mandates in Southeast Asia and the EU.

18+Years direct
P&L responsibility
50+Business types
operated
12Country
markets
$1M+Minimum mandate
enterprise value

UNGLIN Co. Ltd. · Nr. 0505566006201 · Bangkok, Thailand · Sell-Side M&A Advisory for founder-led businesses globally.

The Process

From first call
to closed deal.

01

Discovery Call

30 minutes. Den covers your exit timeline, where the biggest preparation gaps likely are, and whether the Diagnostic makes commercial sense for your situation. If it doesn't, he tells you on the call.

02

Exit Readiness Diagnostic

Three weeks. Four written deliverables. NDA before work begins. See your business the way a buyer sees it — and know exactly what to fix before they arrive. Fixed fee $15K.

03

Sell-Side Mandate

Institutional CIM, targeted buyer outreach, competitive process, LOI to close. Den leads every stage. Monthly retainer plus tiered success fee. Typically 4–9 months from mandate signing.

04

Closed & Clear

Maximum achievable price. Clean deal terms. Cash at close — because the preparation removed every discount a buyer could have applied before they found the problems themselves.

Find out in 30 minutes what your business is actually worth to a buyer.

Book Your Discovery Call → Den takes every call personally · No commitment · No follow-up pressure
Before You Call

Questions that
matter.

No. Den advises founder-led businesses globally. UNGLIN is registered in Bangkok — that is the operational base, not a geographic constraint on where the work is done. The Diagnostic is conducted remotely or in-person at your location. Mandates are run across SE Asia, the UK, Europe, the Middle East, and the Americas. In-person sessions are available anywhere for both the Diagnostic and mandate stages. Current active mandates include businesses in Southeast Asia and the UK.
A paid, fixed-scope engagement over three weeks producing four written deliverables: a quality of earnings pre-assessment identifying the add-backs and normalisation adjustments a buyer's accountant will apply; a management independence assessment documenting what happens to revenue and operations if you step back; a documentation gap report listing what buyers will request in due diligence that you currently do not have; and an indicative valuation range with the specific assumptions driving each end. All four documents are yours permanently — not contingent on whether you proceed to a mandate. Fixed fee $15,000 depending on business size and cross-border complexity, confirmed before Day 1.
Two mechanisms. First: the Diagnostic surfaces discounts before buyers apply them. Every problem a buyer finds in due diligence becomes negotiating leverage — a price reduction, an earn-out, or deal termination. Finding those problems yourself, and fixing what's fixable, removes that leverage before the buyer knows it existed. Second: Firmex and Divestopedia's M&A Fee Guide documents that represented sellers achieve 6–25% higher acquisition premiums than unrepresented sellers. On a $5M transaction, that differential is $300,000–$1,250,000. The combined Diagnostic and advisory fee is a fraction of the lowest end of that range.
The full fee structure is disclosed on the discovery call after Den understands the business complexity and deal size. The structure is: a monthly retainer during the mandate, credited against the success fee at close, plus a tiered success fee on transaction value. Tiered means the percentage declines as deal size increases — consistent with the modified Lehman structure used by 81% of mid-market advisors (Axial/Divestopedia Fee Guide). No success fee is charged if the deal does not close.
81% of legitimate mid-market M&A advisors charge a monthly retainer — this is the documented market standard, not an unusual request (Axial/Divestopedia Fee Guide). An advisor working on success-fee only has multiple mandates running simultaneously and is commercially incentivised to close whichever deal is nearest, not to maximise value on yours. A retainer aligns timelines and qualifies sellers: a founder who won't pay a retainer for a $5M exit process is sending a signal about their commitment to completing it.
The Diagnostic is most valuable when run 12–36 months before intended go-to-market. Building two to four quarters of operational history behind a management independence claim requires time. Finding your biggest documentation gap 18 months before going to market means you can close it before buyers see it. Finding it during due diligence means the buyer prices it into the deal. The indicative valuation range also gives you a documented baseline for capital allocation decisions in the intervening period.
A business broker typically works on deals below $2M in enterprise value, operates on volume, produces a listing summary rather than an institutional CIM, and reaches primarily local or regional buyers rather than PE and family offices. The fee structure also differs: a 10% success-fee on a $5M deal is $500,000 — a retainer plus tiered success fee for an institutional process at this deal size typically produces a lower total advisory cost while delivering a materially more rigorous process and a buyer pool the broker cannot access.
Full NDA signed before any work begins — including the discovery call if you want to share financial details beforehand. All analysis is conducted on UNGLIN's own secured infrastructure. No client data is uploaded to any public platform or external system. Buyer outreach uses phased disclosure: blind teaser first, NDA before CIM, proof of funds before any site visit or management meeting. Your employees, suppliers, and customers do not know the business is for sale until you choose to disclose it.
That is the most commercially valuable outcome the Diagnostic can produce. A seller who discovers a deal-killer before going to market has time to fix it, route around it, or price it honestly. A seller who discovers it when a buyer's due diligence team surfaces it has lost all leverage. Den will tell you clearly what the problems are, in priority order, and what the realistic options are to address them within your timeline. The Diagnostic deliverables are yours regardless — a document that identifies three structural problems and gives you a roadmap has produced commercial value independent of any mandate.
Yes, on a retained basis. PE funds and family offices engage UNGLIN on the buy side for acquisition target assessments and operational due diligence. These engagements are separate from sell-side mandates and priced as fixed-fee per-target work. Buy-side relationships also generate sell-side mandate flow: PE funds regularly refer portfolio companies approaching exit for pre-sale preparation. If you are a fund or family office seeking buy-side support, contact Den directly.
Book Your Call

Start with
30 minutes.

Den takes every first call personally. In 30 minutes: what your exit horizon looks like, where the biggest preparation gaps likely are, and whether the Diagnostic makes commercial sense for your situation right now.

If the economics don't work — because the business is too small, the timeline is too short, or the fit is simply not right — Den tells you that on the call, without pressure and without a follow-up sequence.

If there is a fit, you discuss next steps. NDA before any work begins. No commitment on the call itself.

Location Bangkok, Thailand · In-person available globally for mandates
What happens on the call

Three things in 30 minutes: what your business looks like and where it is heading, where the most likely preparation gaps are based on what Den hears, and whether the Diagnostic produces a commercial return that justifies the fee for your specific situation. If it does, you discuss a start date. If it does not, Den tells you what would need to change — and means it.

Book Your Discovery Call →

Typical response within one business day. Den answers directly — no account management layer, no qualifying team, no follow-up sequence.

* 6–25% premium: Firmex / Divestopedia North American M&A Fee Guide 2024–25, represented vs. unrepresented sellers.  |  59% PE buyer figure: IBBA & M&A Source Market Pulse Q2 2025 — PE buyers as % of all transactions in the $5M–$50M enterprise value segment (North American dataset). PE underwriting criteria and institutional CIM requirements are consistent globally among institutional buyers.  |  Diagnostic fee range $15,000 USD. Exact fee confirmed on discovery call based on business complexity and geography.